Arecor Therapeutics Liabilities 2024

Liabilities Details

Assessing Arecor Therapeutics's Liabilities

Arecor Therapeutics's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Arecor Therapeutics's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Arecor Therapeutics's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Arecor Therapeutics's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Arecor Therapeutics’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Arecor Therapeutics stock

What is the level of liabilities of Arecor Therapeutics this year?

Arecor Therapeutics has a debt balance of 5.85 M GBP this year.

What were the liabilities of Arecor Therapeutics compared to the previous year?

The liabilities of Arecor Therapeutics have increased by 35.73% increased compared to the previous year.

What are the consequences of high debt for investors of Arecor Therapeutics?

High liabilities can pose a risk for investors of Arecor Therapeutics, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Arecor Therapeutics?

Low liabilities mean that Arecor Therapeutics has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Arecor Therapeutics affect the company?

An increase in liabilities of Arecor Therapeutics can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Arecor Therapeutics affect the company?

A decrease in the liabilities of Arecor Therapeutics can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Arecor Therapeutics?

Some factors that can influence the liabilities of Arecor Therapeutics include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Arecor Therapeutics so important for investors?

The liabilities of Arecor Therapeutics are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Arecor Therapeutics take to modify the liabilities?

To change its liabilities, Arecor Therapeutics can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Arecor Therapeutics pay?

Over the past 12 months, Arecor Therapeutics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Arecor Therapeutics is expected to pay a dividend of 0 GBP.

What is the dividend yield of Arecor Therapeutics?

The current dividend yield of Arecor Therapeutics is .

When does Arecor Therapeutics pay dividends?

Arecor Therapeutics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Arecor Therapeutics?

Arecor Therapeutics paid dividends every year for the past 0 years.

What is the dividend of Arecor Therapeutics?

For the upcoming 12 months, dividends amounting to 0 GBP are expected. This corresponds to a dividend yield of 0 %.

In which sector is Arecor Therapeutics located?

Arecor Therapeutics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Arecor Therapeutics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Arecor Therapeutics from 10/1/2024 amounting to 0 GBP, you needed to have the stock in your portfolio before the ex-date on 10/1/2024.

When did Arecor Therapeutics pay the last dividend?

The last dividend was paid out on 10/1/2024.

What was the dividend of Arecor Therapeutics in the year 2023?

In the year 2023, Arecor Therapeutics distributed 0 GBP as dividends.

In which currency does Arecor Therapeutics pay out the dividend?

The dividends of Arecor Therapeutics are distributed in GBP.